entertainment -WSS

entertainment

author：comprehensive 2025-09-28 01:40:07 - browse：852

Chief executive officer of Sanofi Paul Hudson, wearing glasses, speaks into a mic — pharma coverage from STAT — Sanofi CEO Paul Hudson Carolyn Kaster/AP

LONDON — Sanofi CEO Paul Hudson on Wednesday defended his company’s recent moves to abandon future profit guidance and up its investment in its own research programs, arguing that the dramatically negative market response didn’t reflect the potential rewards that could stem from the plan.

“Would I have liked the stock market reaction to be more generous? Of course,” Hudson said at a Financial Times event in London. “But this is a long-term game, and if you’re trying to deliver long-term value, you try not to make too many short-term decisions.”

Sanofi unveiled its R&D plans late last month as it announced its third-quarter performance and said that it was spinning out its consumer health division. As the company said it was going to spend more money on research, it also withdrew earnings outlooks for 2025. Company executives have argued that this was the moment — when Sanofi has a strong pipeline and isn’t facing patent expirations for years — to increase its R&D resources, even at the expense of short-term profits.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： Readout Newsletter: The latest in Pfizer, Moderna, and Sanofi

WSS

Legitimacy of 'customer' in Supreme Court gay rights case raises ethical, legal flags

Mayo Clinic plans $5B tech

3 killed, 8 injured in late

Brazil's Neymar fined $3.3 million for illegal artificial lake at mansion outside Rio

CDC director unscathed in first congressional testimony

Masked assailants attack a journalist and a lawyer in Russia's Chechnya province

knowledge

entertainment

hotspot

How one medical school became remarkably diverse

Pediatric cancer treatments threatened by a new FDA policy

Affirmative action in medical school literally saved lives

Leon Gautier, last member of French D

Apple is now the first public company to be valued at $3 trillion

UnitedHealth’s Optum accused of antitrust violations in California

At least 13 dead in Texas as scorching temps continue

Michigan man accused of striking an officer during the US Capitol attack is arrested in Florida

Virginia high school admissions case could be legal follow

U.K. Biobank has 500,000 peoples' genome sequences available

entertainment

10 states plan to sue EPA over standards for residential wood

Organ aging and disease risk measured by new blood test

ReNAgade cuts staff seven months after raising $300 million

Brazil's Neymar fined $3.3 million for illegal artificial lake at mansion outside Rio

CDC director unscathed in first congressional testimony

J&J to emphasize cancer drugs, stop much of its vaccine research

hotspot

explore

entertainment

hotspot